Abstract：
OBJECTIVE: Uterine fibroids are relatively common in reproductive-age women and are directly linked to pregnancy. There are many debates about performing a myomectomy at the same time as a caesarian section (CS) in such cases due to the risk of a hemorrhage. Our study aims to investigate fibroid features and their evolution in pregnancy, complications of a myomectomy during CS and maternal and fetal obstetric outcomes of pregnancies with fibroids.
METHODS: We realize a prospective study that includes 57 patients with fibroids in pregnancy diagnosed in January 2017-June 2019. We analyze the number, the location and the growth of fibroids during pregnancy and the maternal and fetal outcome. We appreciate the bleeding in patients with a myomectomy and without a myomectomy during CS, using hemoglobin values before and after birth.
RESULTS: Most of the patients present single fibroids that are 30-160 mm in size, located on the anterior uterine wall. Vaginal delivery is used in 7% of women, whereas 85.96% deliver by CS. In addition, 68% of fibroids are diagnosed in the first trimester. In most cases, the fibroid has maximum growth in the second trimester of pregnancy. The myomectomy rate for fibroids during CS is 24.48. Hemoglobin values showed no statistically significant difference between the two groups with and without myomectomy. The operating time is double for the group with a myomectomy associated with a CS. The results of the obstetric outcomes are abortion in 7% of all patients, whereas premature delivery and births at term are 9.43% and 90.57%, respectively.
CONCLUSIONS: The decision of performing a myomectomy during pregnancy can be a challenge and must be performed for selected cases. This procedure may have several benefits, such as avoiding another operation to remove fibroids.
METHODS: We realize a prospective study that includes 57 patients with fibroids in pregnancy diagnosed in January 2017-June 2019. We analyze the number, the location and the growth of fibroids during pregnancy and the maternal and fetal outcome. We appreciate the bleeding in patients with a myomectomy and without a myomectomy during CS, using hemoglobin values before and after birth.
RESULTS: Most of the patients present single fibroids that are 30-160 mm in size, located on the anterior uterine wall. Vaginal delivery is used in 7% of women, whereas 85.96% deliver by CS. In addition, 68% of fibroids are diagnosed in the first trimester. In most cases, the fibroid has maximum growth in the second trimester of pregnancy. The myomectomy rate for fibroids during CS is 24.48. Hemoglobin values showed no statistically significant difference between the two groups with and without myomectomy. The operating time is double for the group with a myomectomy associated with a CS. The results of the obstetric outcomes are abortion in 7% of all patients, whereas premature delivery and births at term are 9.43% and 90.57%, respectively.
CONCLUSIONS: The decision of performing a myomectomy during pregnancy can be a challenge and must be performed for selected cases. This procedure may have several benefits, such as avoiding another operation to remove fibroids.
摘要：
目的：子宫肌瘤在育龄妇女中相对常见，与妊娠直接相关。在这种情况下，由于出血的风险，关于与剖腹产（CS）同时进行子宫肌瘤切除术存在许多争论。我们的研究旨在调查子宫肌瘤的特征及其在怀孕期间的演变，CS期间子宫肌瘤切除术的并发症以及子宫肌瘤妊娠的母体和胎儿产科结局。
方法：我们实现了一项前瞻性研究，该研究包括2017年1月至2019年6月诊断的57例妊娠子宫肌瘤患者。我们分析数字，妊娠期间肌瘤的位置和生长以及母婴结局。我们赞赏在CS期间进行子宫肌瘤切除术和未进行子宫肌瘤切除术的患者出血，使用出生前后的血红蛋白值。
结果：大多数患者出现大小为30-160毫米的单个肌瘤，位于子宫前壁。7％的女性使用阴道分娩，而85.96%由CS提供。此外,68%的肌瘤在妊娠早期被诊断。在大多数情况下,子宫肌瘤在妊娠中期有最大的生长。CS期间肌瘤的肌瘤切除率为24.48。有和没有子宫肌瘤切除术的两组之间的血红蛋白值没有统计学上的显着差异。与CS相关的子宫肌瘤切除术组的手术时间是两倍。产科结果的结果是所有患者中有7％流产，早产和足月分娩分别为9.43%和90.57%，分别。
结论：决定在妊娠期间进行子宫肌瘤切除术可能是一个挑战，必须对某些病例进行。此程序可能有几个好处，例如避免另一个手术切除肌瘤。
方法：我们实现了一项前瞻性研究，该研究包括2017年1月至2019年6月诊断的57例妊娠子宫肌瘤患者。我们分析数字，妊娠期间肌瘤的位置和生长以及母婴结局。我们赞赏在CS期间进行子宫肌瘤切除术和未进行子宫肌瘤切除术的患者出血，使用出生前后的血红蛋白值。
结果：大多数患者出现大小为30-160毫米的单个肌瘤，位于子宫前壁。7％的女性使用阴道分娩，而85.96%由CS提供。此外,68%的肌瘤在妊娠早期被诊断。在大多数情况下,子宫肌瘤在妊娠中期有最大的生长。CS期间肌瘤的肌瘤切除率为24.48。有和没有子宫肌瘤切除术的两组之间的血红蛋白值没有统计学上的显着差异。与CS相关的子宫肌瘤切除术组的手术时间是两倍。产科结果的结果是所有患者中有7％流产，早产和足月分娩分别为9.43%和90.57%，分别。
结论：决定在妊娠期间进行子宫肌瘤切除术可能是一个挑战，必须对某些病例进行。此程序可能有几个好处，例如避免另一个手术切除肌瘤。
